Covid-19 News

    Quote from Wyttenbach

    Claiming vaccination is better than natural immunity by using improper aligned data. Reality (Israel 2 mio base data): Natural infection protects at least 25x better than "vaccine" (Pfizer)!

    I have some sympathy with that claim. Natural immunity after severe disease can protect the survivors well. You might though argue that those predisposed to die would already be dead.


    But:

    (1) You agree that mild infections (even more asymptomatic infections) protect much less well than serious infections

    (2) You are (at best - I do not trust figures without detailed references) looking at protection from symptomatic and reported infections. That misses a lot of the least protective infections.


    Anyway - using improper aligned data for claims is not quite as bad as claims based on no data at all. Or claims based on raw data that ignore Simpsons Paradox etc.

    Quote from THHuxleynew

    I have some sympathy with that claim. Natural immunity after severe disease can protect the survivors well.

    My neighbor had 3 days CoV-19 symptoms and did use our old antiviral cure. He just made his second antibody test that did show highly elevated IG-G in the top 20%. The lab comment: Must be short after infection in fact almost 1 year back...


    So the true CoV-19 protection is getting it with early cure. As recent papers do show. Also a soft infection protects strong enough as IG-G steadily increase over time!


    Wrong way to do it:: Monoclonal cancer chemo (Pfizer, Oxford,J&J) that produces single type antibodies without proper immune memory hence no lasting protection. Question:: Why should a chemo do this anyway???

    Quote from Alan Smith

    VACCINE PASSPORT CHAOS - The Economist magazine.

    .Someday, vaccine passports might help keep the peace. But right now the world must focus on winning the war.

    IMO the chaos is yet to come, when the decision makers start to realize (or it can't be ignored anymore) that vaxx. persons can also spread the virus! So far in AT, vaxx. persons don't need to test for their personal "freedoms". This is risky, because we have obviously many "breakthrough" infections. Breakthrough infections seem to be rather usual than exception.


    AND I truly believe that we can't win the war with these types of vaccines!

    Quote from gerold.s

    hen the decision makers start to realize (or it can't be ignored anymore) that vaxx. persons can also spread the virus! So far in AT, vaxx. persons don't need to test for their personal "freedoms". This is risky, because we have obviously many "breakthrough" infections. Breakthrough infections seem to be rather usual than exception.

    It is true that VE against infections is no more than about 80% - and goes down with age. So they will be common if the infection rate is high.


    All of the COVID social distancing measures have two elements, which interact:

    How muhc does it reduce R

    Does adding it, on average, make people behave more or less in a way that will reduce R


    After all, it is population behaviour, voluntarily, that has the main effect on R.


    The US seems to have lost the plot with poisonous politics, idiots who view regulations to help deal with COVID surges as some sort of major assault on personal liberty, and high levels of vaccine hesitancy.


    The main factor for decision-makers is whether a mandate / passport / etc will increase vaccine take-up, or decrease it.


    If it increases take-up - that overall has a much larger effect on hospital overload (the thing decision-makers fear) - than anything else. Regardless of whether it reduces R.


    Worth remembering that reducing R is about spreading the infection over a longer time and preventing epidemic-like large short-term peaks. In the end everyone will be protected, a bit, by vaccine or infection.


    Quote from gerold.s

    AND I truly believe that we can't win the war with these types of vaccines!

    Compare it with Flu, we will never win the way against Flu, but unless we get a completely new variant emerging from animals it does not kill many people. Vaccines reduce the number of people who die, by a number that varies between 30% and 70%.


    COVID is much worse because still so many people in developed countries have not been infected, and therefore have that large no-prior-immunity IFR in absence of vaccine. In a few years time enough people will have been infected that risks are lower. I don't think we can easily know yet what will e the risks than compared with Flu.


    Also, if you want better vaccines - ask the decision-makers to green-light a delta-specific vaccine. Much more effective against delta and also likely more effective against the next delta-derived variant that evades current vaccine.


    The conversation on the internet (and here) seems to be polarised into those who give clearly too good interpretations of vaccine effectiveness, and those (antivaxxers) who give clearly too bad interpretations.


    A lot of people in the middle - and I blame politicians for this - had over-high hopes for what a vaccine could do - based on what it would have done against original COVID - and do not adjust to what it does against delta.


    But at the start we were not sure we would have a vaccine even as good as that for Flu. We have a vaccine - even against delta - that is still a lot better than the Flu vaccine.


    People want COVID to go away understandably and the vaccines are now being seen as not working because they are not delivering that. Yet that was always a hope - and the necessity was a vaccine good enough to allow developed countries to open up without crashing their health systems.


    I have some sympathy with the view that it might be better overall for society to let people with COVID die at home than have lockdown: the overall damage is so much less. That could never work because people are human, and they will in that case be afraid of the virus. In addition they will clamour for their loved ones to be saved when needed y hospital and ICU when there is not the caapcity to do this. When you think it through, unlkess yoiu can keep the need for health demand low and people feeling save, it does not work.


    You can see politicians talking up VE as actually what is needed to open up the economy and get people out again. It is a razor-edge problem. Tell them it is all over (like Boris Johnson in the UK) you get a very large spike in infections and even with high vaccination we may have big trouble this winder. On the other hand, the worse things are then, the better off we will be next year. Vaccination reduces R, even though not as muhc as we would like, so with this perilous balance in place it can make a big difference between R = 1.1 and R = 0.9.


    Take for example India. They had a terrible COVID 2nd wave, 70% of people infected. After that, it is much easier for them to keep R low now. That also applies between different parts of a country. You can see that the US states that have a very bad time in teh last 6 months will have less trouble after it, whereas the states that had low COVID rates over the Summer will probably struggle in winter.


    Getting it right, to keep things open and COVID rates within bound, is so difficult because epidemics increase and decrease exponentially.


    The one constant is that without vaccine we would either totally crash the health system in ways no democratic politician could withstand (look at Bolsanaro) or take a lot longer, at necessary lower infection rates, to have enough natural immunity.


    The thing that is uncertain is how long does natural immunity, or vaccine immunity, last. They both reduce over time. If we had a delta-specific vaccine the initial levels of antibodies would be much higher, and it would last longer. Even so, reducing over time in both cases does not mean there is no benefit, the reduction in hospitalisation and death from the vaccine looks constant out to +5 months while VE against infection wanes:


    New USA study confirms VE wanes to ~50% after 5m, but VE vs. hospitalization remains strong at >90%
    A paper published October 4, 2021 in The Lancet based on >3.4m USA patients found Pfizer vaccine effectiveness (VE) vs. infection decreased from 88% 1m after…
    www.covid-datascience.com

    Did they lie?


    The US (and to a lesser extent UK) politicians were always until very recently using VE data against original COVID. That was fair, because it takes time to get good data and analysis and you need multiple studies - one can be an outlier. They did not emphasise to everyone - we now have delta - no-one knows for sure how well vaccines will work against delta.


    That was arguably misleading. What would you have done? Had they emphasised the FUD - and waited 6 months for the good but not perfect truth to emerge - would it have been betetr for their countries?


    At least in the UK no-one was lying - they were just, as politicians always do, choosing what to say.


    In terms of personal decisions it makes no difference - we knew very quickly that VE against hospitalisation and death was good enough for taking the vaccine to be a no-brainer.


    Then there is this whole internet and political storm about rights, freedoms, blah, blah. I have a lot of sympathy with Greta T. Politicians, and internet campaigns, can make a lot of noise that has nothing to do with the real underlying questions and prevents people thinking about them.


    In this case much as a dislike Boris J's incompetent government in the UK it is not clear any of the decisions about restrictions now are being made wrong, even though it is a risk and we may end up thinking they should have been different.


    COVID is something where democratic politicians get punished within 2 yaers if they get it wrong. They are therefore all highly motivated to get it right - even if no-one knows what that is.


    All we can say is that the antivax anti-expert fringe - posted here continuously from TSN - makes getting it right more difficult for sure.


    THH

    Brazilian clinical trial with unapproved Indian vaccine – Covishield – hopes to demonstrate a reduction in the number of cases of COVID-19 after 2 doses


    Brazilian clinical trial with unapproved Indian vaccine - Covishield - hopes to demonstrate a reduction in the number of cases of COVID-19 after 2 doses
    An interventional and comparative clinical trial (NCT05059106) conducted by the Federal University of Espirito Santo/Brazil in collaboration with René
    trialsitenews.com


    An interventional and comparative clinical trial (NCT05059106) conducted by the Federal University of Espirito Santo/Brazil in collaboration with René Rachou Institute/Fiocruz-MG, the National School of Public Health Sérgio Arouca/Fiocruz, and Sciences Superior School of the Santa Casa de Misericórdia de Vitória is testing the efficacy, safety, and immunogenicity of the Covishield [ChAdOx1 nCoV-19/AZD1222] vaccine to protect against coronavirus infection (SARS-CoV2) administered in half a dose when compared to individuals immunized by full dose.


    The clinical trial (NCT05059106) is expected to provide data on the efficacy of protection, induced administration, and immunogenicity in individuals who will receive half a dose of Covishield ChAdOx1 nCoV-19 vaccine (AZD1222) in a 02-dose regimen administered in an 8-week interval to participants of both sexes between ages 18 and 19 years living in the municipality of Viana (State of Espírito Santo-BR). Approximately 29,637 participants in the study were estimated to cover the 85% of the target population at the study’s development site. The groups will be divided into an experimental group and comparative group. The experimental group (Group1) is composed of individuals aged 18 to 49 years from the city of Viana – Espírito Santo (ES)/Brazil, not belonging to priority groups, not immunized for any vaccine intended for protection of COVID-19, and/or coronavirus-infected who will receive half a dose of ChAdOx1 nCoV-19 vaccine in a 02-dose vaccination schedule in 08 weeks. The comparative group (Group 2) includes healthcare professionals aged 18 to 49 years old who received a standard dose of the ChAdOx1 nCoV-19 vaccine in a 02-dose vaccination schedule within 08 weeks. The data and follow-up of the participants will be obtained after 28 days and over 12 months of the administration of the 2nd dose. The start date of the study is scheduled for June 1st, 2021 and its end date, June 1st, 2022. The completion of the clinical trial is expected in October 2022. In the main outcome, there is expected to be a 60% reduction in new cases of COVID-19 within 12 months after the administration of the entire vaccination schedule in two doses. For the secondary outcome, clinical-epidemiological variables such as several positive cases for COVID.19, deaths with Specific ICD for COVID-19, hospitalizations due to respiratory complications attributed to SARS-CoV2, and testing as well as positive results by RT-PCR for coronavirus will be extracted from databases such as e-SUS VS, eSUS notifies and datasus. Vaccine-induced cellular and humoral immunity will be evaluated through viral neutralization tests, standard serological tests, IgM, and IgG specific dosage for SARS-CoV2 proteins, the dosage of humoral factors such as cytokines and growth factors, stimulation of peripheral mononuclear blood cells, production of Memory-specific T and B cells for Coronaviruses as well as production of cytoplasmic molecules. The immunogenicity produced by vaccination in 600 subsamples of the eligible population will be evaluated in a comparative nature with a reference group composed of health professionals who received standard Covishield vaccine doses (ChAdOx1). The researchers hope to prove a similar reduction in the incidence of COVID-19 in a half-dose administration when compared to the group that received a standard dose.


    About Covishield (ChAdOx1)

    The vaccine called Covishield (ChAdOx1) is produced by the Indian company Serum Institute of India Unip. Ltd. They are considered the world’s largest vaccine manufacturer in doses produced and sold globally (more than 1.5 billion doses). In addition to Covishield, other vaccines such as polio protection, recombinant hepatitis B, and measles are also manufactured and distributed. CoviShield is a monovalent vaccine composed of a single chimpanzee recombinant adenovirus vector, deficient for replication and encoding SARS-CoV-2 glycoprotein S. After administration, this glycoprotein S is expressed locally and stimulates a humoral and cellular immune response. This vaccine does not have marketing authorization, but it has received a restricted use license for emergency situations. The approval grants permission for the vaccine to be used for active immunization of individuals 18 years and older for the prevention of coronavirus disease 2019 (COVID-19).


    Principal/Lead Researcher

    José G. Mill, Ph.D. – Holds a bachelor’s degree in Medicine from the Federal University of Espírito Santo, a Master’s degree in Biophysics from the Federal University of Rio de Janeiro, and a Ph.D. in Pharmacology from the Ribeirão Preto School of Medicine, University of São Paulo. He is a Professor of Physiology of the Department of Physiological Sciences, and a permanent professor of the Graduate Programs in Physiological Sciences and Collective Health of the Center for Health Sciences of UFES. He is a full partner of the Brazilian Society of Physiology (SBFis) and the Brazilian Society for the Progress of Science (SBPC). He is a researcher 1A at CNPq and coordinator of the ELSA Research Center (Longitudinal Study of Adult Health) in Espírito Santo.


    Call to action: Trialsite News will monitor and update the results of this and other Brazilian studies for our community


    EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19 - Full Text View - ClinicalTrials.gov
    EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19 - Full Text View.
    clinicaltrials.gov

    Well its still two steps forward three steps backwards! At least the drug companies at long last are utilizing anti-viral therapies which I have been banging on about ever since the beginning of this thread. Avigan, Favivipir hydroxychloroquine, Avermectins and a host of well-known and low toxicity Anti-Bat compounds should be taken alongside the vaccines. Or are the vaccines completely useless? As they are against most other coronavirus or indeed HIV species? Its easy to predict there will be a massive rise in COVID cases following any relaxation of isolation rules as in the English half-term holidays are being pursued with no diligent mask-wearing, again breaking all the sensible quarantine rules. There is the trade-off-how many new COVID DEATHS in exchange for two weeks of relative freedom ie freedom with your relatives who are all about to be infected?

    I guess this is a right-wing anti vax study from TSN . Someone really needs to get a grip!



    Children’s Hospital of Los Angeles Study Finds Risks for Severe COVID in Adolescents and Adults is a Function of Being Overweight or Obese


    Children’s Hospital of Los Angeles Study Finds Risks for Severe COVID in Adolescents and Adults is a Function of Being Overweight or Obese
    While the media and much of the government apparatus continuously project that COVID-19 is just as dangerous for all social and demographic cohorts, this
    trialsitenews.com


    While the media and much of the government apparatus continuously project that COVID-19 is just as dangerous for all social and demographic cohorts, this isn’t the case as the elderly with comorbidities are far more at risk than young, healthy persons. Recently, researchers from Children’s Hospital Los Angeles studied risk in more detail and discovered that age and being overweight or obese are associated with more severe COVID-19 outcomes, particularly respiratory symptoms. However, the study team declared they still are not aware if age and obesity represent risk factors for milder COVID-19 cases. The study was led by corresponding author Pia S. Pannraj with Children’s Hospital Los Angeles and the University of Southern California. The study team also noted the overwhelming evidence that children hospitalized for COVID-19 struggle with diagnoses involving overweight and obesity (OWOB).


    The study team reports that being overweight or obese as an adolescent or adult is associated with worse respiratory symptoms that also last longer. The association with weight was not observed in children under 12 who overall have significantly fewer symptoms than adults and adolescents. This is significant information for parents as COVID vaccines for 5 to 11-year-olds are on the brink of being authorized for emergency use.


    The Study

    Called the Household Exposure and Respiratory Virus Transmission and Immunity Study (HEARTS), the study team recruited and enrolled individuals who were within two weeks of exposure to a laboratory-confirmed COVID-19 household contact.


    Discussion

    TrialSite notes that nearly two-thirds of the HEARTS study participants included people who were either overweight or obese (OWOB), which is reflective of worsening obesity trends in America and worldwide. The authors note that the effect of the COVID-19 pandemic and associated lockdowns didn’t help the obesity epidemic at all. With more time inside and increasingly bad diets, not to mention more online time, studies suggest conditions are only worsening.


    Given ongoing circulation of SARS-CoV-2 and variants, the study team reports that in the “predominantly outpatient cohort, COVID-19-infected individuals with OWOB experience more symptoms, especially respiratory symptoms of cough and shortness of breath, compared with individuals without OWOB.”


    The Children’s Hospital of Los Angeles investigators share that the study observations align with other research reporting greater risks for severe outcomes in COVID-19 hospitalized patients with OWOB—this includes not only ICU admissions but invasive mechanical ventilation and death.


    Specifically, the authors report that 552 patients were enrolled in the study from June 2020 to January 2021. Of this total 470 (85.1%) tested affirmative for COVID-19 including 261 (55.5%) adults, 61 (13.0%) adolescents 12 to17 years, and 148 (31.5%) children <12 years.


    The study team found that children had far fewer symptoms (median 2 vs.3, p < 0.001); with shorter duration (median 5 vs. 7, p < 0.001) compared with adolescents and adults.


    The authors share that OWOB is classified by those with a body mass index of 300 (63.8%). In alignment with several other studies and anecdotal data those patients struggling with OWOB fare worse than those without OWOB (median 3 vs. 2, p = 0.037), including more severe coughs and shortness of breath (p = 0.023 and 0.026, respectively).


    Moreover, those adolescents with OWOB face greater symptomatic issues (66.7% vs. 34.2%, p = 0.008) while also experiencing longer respiratory symptoms (median 7 vs. 4 days, p = 0.049 ) as compared to adolescents without OWOB.


    TrialSite reports that it is worth noting that one source referenced in the article reveals that of the hospitalized adolescents in the Spring of 2021 for COVID-19, 71% had one or more underlying medical conditions, obesity being the most common (36%). Of course, this study didn’t cover data during the height of the Delta surge, which may have altered the findings, although the strong association between obesity and more severe COVID appears to have held during the Delta wave as well.


    Lead Research/Investigator

    Pia S. Pannraj, MD, MPH, Children’s Hospital, Los Angeles, Division of Infectious Diseases, University of Southern California, Los Angeles, Keck School of Medicine, Department of Pediatrics and Molecular Microbiology and Immunology.


    Error - Cookies Turned Off

    The sun is the biggest influence on the virus. Read Hope-Simpson! NASA has confirmed we are in a solar minimum, yet since July of 2020 sunspot activity is the highest in recorded history and Earth's magnetic field is at it's lowest. Wakeup all you Mensa minds!


    NASA confirms massive solar flare will hit Earth, arrival time found

    NASA's Solar Dynamics Observatory has confirmed that a massive solar flare has erupted from an Earth-facing sunspot on October 28.


    NASA confirms massive solar flare will hit Earth, arrival time found
    NASA's Solar Dynamics Observatory has confirmed that a massive solar flare has erupted from an Earth-facing sunspot on October 28.
    www.tweaktown.com

    Vitamin D deficiency visible for the first time in teeth after cremation

    Even after burning at high temperatures, scientists were able to see signs of deficiency, which could give insight into how past populations lived


    https://thehill.com/changing-a…le-for-the-first-time?amp.


    Story at a glance

    Lack of time in the sun can lead to vitamin D deficiency.

    Researchers can find signs of this deficiency in remains of people who have died, even in their teeth.

    A team based in Belgium tested archeological teeth at temperatures similar to cremation to compare visible signs of vitamin D deficiency.

    Vitamin D can become deficient with lack of exposure to the sun, and many doctors recommend taking a supplement to make up for it. Researchers and experts are exploring ways to study vitamin D levels and deficiencies in past populations. One team has been doing this by looking at teeth from archeological sites and mimicking cremation temperatures.


    In a study published in Scientific Reports, a team based in Belgium burned teeth for varying amounts of time and at different temperatures to test if they could see signs of vitamin D deficiency after burning. The researchers obtained 17 pairs of teeth from archeological collections in Belgium and the Netherlands. The team burned one tooth from each pair at temperatures varying from 600 to 900 degrees Celsius

    The researchers compared what they could see in the burned results with thin sections from the unburned tooth from each pair examined under a microscope. They looked for signs of interglobular dentine, a mineralization that can occur when there's a deficiency of vitamin D in the body. They saw that the defect was still visible in the burned teeth even at the highest temperatures, suggesting that they would be detectable in human cremation remains as well.

    Interestingly, they were also able to estimate the age of occurrence as well as the severity of interglobular dentine. "The results from our study represent a major step forward in the fields of biological anthropology, archaeology, and palaeopathology by opening up a variety of new possibilities for the study of health and activities related to sunlight exposure of numerous past populations that practiced cremation as their funerary ritual," says Barbara Veselka at Vrije Universiteit Brussel in a press release.

    Quote from gerold.s

    Breakthrough infections seem to be rather usual than exception.

    In fact up to 6x higher (UK) among vaccinated.


    Quote from THHuxleynew

    the reduction in hospitalisation and death from the vaccine looks constant out to +5 months while VE against infection wanes:

    This is a false claim as the risk of vaccinated after infection is 5x higher for death!!

    All other countries than USA actually show 50% protection from death!...

    This is a breakthrough': Researchers identify potential new drug treatment for COVID-19


    `This is a breakthrough`: Researchers identify potential new drug treatment for COVID-19 , Science News | wionews.com


    The researchers from the University of Kent in the UK and Goethe-University in Germany have identified a potential new drug treatment that suppresses the reproduction of the SARS-CoV-2 virus that causes COVID-19.

    The researchers have stated that to multiply, all viruses infect cells and reprogramme them to produce novel viruses. The study, published recently in the journal Metabolites titled "Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy", shows that cells infected with SARS-CoV-2 can only produce novel coronaviruses when a metabolic pathway called pentose phosphate pathway is activated.


    As per researchers, the drug benfooxythiamine (BOT), an inhibitor of this metabolic pathway, suppressed the reproduction of SARS-CoV-2, and infected cells did not produce coronaviruses.

    A part of the study read: "Notably, metabolic drugs like BOT and 2DG may also interfere with COVID-19-associated immunopathology by modifying the metabolism of immune cells in addition to inhibiting SARS-CoV-2 replication. Hence, they may improve COVID-19 therapy outcomes by exerting antiviral and immunomodulatory effects."


    This shows that pentose phosphate pathway inhibitors like benfooxythiamine are a potential new treatment option for COVID-19, both on their own and in combination with other treatments.


    Additionally, Benfooxythiamin's antiviral mechanism differs from that of other COVID-19 drugs such as remdesivir and molnupiravir. Therefore, viruses resistant to these may be sensitive to benfooxythiamin.

    Professor Martin Michaelis, University of Kent, said: "This is a breakthrough in the research of Covid-19 treatment. Since resistance development is a big problem in the treatment of viral diseases, having therapies that use different targets is very important and provides further hope for developing the most effective treatments for Covid-19."



    Professor Jindrich Cinatl, Goethe-University Frankfurt, said: "Targeting virus-induced changes in the host cell metabolism is an attractive way to interfere specifically with the virus replication process."


    It is a cheap repurposed drug!

    The nejm must be another right-wing anti vax study. It reports Pfizer vaccine sucks across all age groups


    Waning Immunity after the BNT162b2 Vaccine in Israel


    https://www.nejm.org/doi/full/10.1056/NEJMoa2114228?query=featured_home


    Abstract

    BACKGROUND

    In December 2020, Israel began a mass vaccination campaign against coronavirus disease 2019 (Covid-19) by administering the BNT162b2 vaccine, which led to a sharp curtailing of the outbreak. After a period with almost no cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, a resurgent Covid-19 outbreak began in mid-June 2021. Possible reasons for the resurgence were reduced vaccine effectiveness against the delta (B.1.617.2) variant and waning immunity. The extent of waning immunity of the vaccine against the delta variant in Israel is unclear.


    METHODS

    We used data on confirmed infection and severe disease collected from an Israeli national database for the period of July 11 to 31, 2021, for all Israeli residents who had been fully vaccinated before June 2021. We used a Poisson regression model to compare rates of confirmed SARS-CoV-2 infection and severe Covid-19 among persons vaccinated during different time periods, with stratification according to age group and with adjustment for possible confounding factors.


    RESULTS

    Among persons 60 years of age or older, the rate of infection in the July 11–31 period was higher among persons who became fully vaccinated in January 2021 (when they were first eligible) than among those fully vaccinated 2 months later, in March (rate ratio, 1.6; 95% confidence interval [CI], 1.3 to 2.0). Among persons 40 to 59 years of age, the rate ratio for infection among those fully vaccinated in February (when they were first eligible), as compared with 2 months later, in April, was 1.7 (95% CI, 1.4 to 2.1). Among persons 16 to 39 years of age, the rate ratio for infection among those fully vaccinated in March (when they were first eligible), as compared with 2 months later, in May, was 1.6 (95% CI, 1.3 to 2.0). The rate ratio for severe disease among persons fully vaccinated in the month when they were first eligible, as compared with those fully vaccinated in March, was 1.8 (95% CI, 1.1 to 2.9) among persons 60 years of age or older and 2.2 (95% CI, 0.6 to 7.7) among those 40 to 59 years of age; owing to small numbers, the rate ratio could not be calculated among persons 16 to 39 years of age.


    CONCLUSIONS

    These findings indicate that immunity against the delta variant of SARS-CoV-2 waned in all age groups a few months after receipt of the second dose of vaccine.

    How UK HSA tries to cheat people about the up to > 5x CoV-19 rates among vaccinated:


    • people who are fully vaccinated may be more health conscious and therefore more likely to get tested for COVID-19 :: The opposite is true vaccinated believe they can't get it and don't test --> undercounting!

    • people who are fully vaccinated may engage in more social interactions because of their vaccination status, and therefore may have greater exposure to circulating COVID-19 infection. OK here they confess that HSA rules are nonsense ...but the others protect much better...

    • people who are unvaccinated may have had past COVID-19 infection prior to the 4-week reporting period in the tables above, thereby artificially reducing the COVID-19 case rate in this population group, and making comparisons between the 2 groups less valid.


    Exactly the opposite is true 50..70% of UK already had a CoV-19 infection. These are counted into the vaccinated cohort instead of excluding them...So this is a 1000% bullshit argument.


    HSA still claims vaccines are the best protection

    Quote from uncertainH

    I think that certain people should not be allowed into restaurants unless they have a low enough weight. Obese people are putting us all at risk !! :) We need to at weigh scales at the entrance of every indoor space.

    More to the point, why hasn't the FDA the NIH or the CDC taken a more public stance on this? Instead we get covers of two seapigs dancing under the headline, THIS IS HEALTHY! That's why we have the 37th ranked healthcare system in the world!!!!!!!!!!!!!!

    IVERMECTIN SAVES INDIA


    #IndiaFightsCorona COVID-19
    www.mygov.in

    (31.10.2021)

    Kerala is enlarging its share in all India cases as Tamil Nadu and Maharastra catch up with Ziverdo therapy.

    Further:: Kerala has to get rid of about 6'000 CoV-19 deaths they did hide during the last 6 months... So every day (since one week now) they log about 300..600 extra deaths to cheat the world wide statistics ... Effective deaths of Kerala today: 62

    Kerala reports 7,427 COVID-19 cases, 62 deaths in last 24 hours
    Thiruvananthapuram (Kerala) [India], October 30 (ANI): Kerala has reported 7,427 new COVID-19 cases and 62 deaths in the past 24 hours.
    www.aninews.in


    All India deaths: Real number 150!

Subscribe to our newsletter

It's sent once a month, you can unsubscribe at anytime!

View archive of previous newsletters

* indicates required

Your email address will be used to send you email newsletters only. See our Privacy Policy for more information.

Our Partners

Supporting researchers for over 20 years
Want to Advertise or Sponsor LENR Forum?
CLICK HERE to contact us.